In mice, IFITM3 KO reduced amyloid plaque formation, while enhanced association between IFITM3 and ɣ-secretase complexes were noted in patients with late onset Alzheimer's disease. This evidence concerns the gene IFITM3 and early-onset autosomal dominant Alzheimer disease.